Published in Immunol Rev on November 01, 2014
Monocytes in myocardial infarction. Arterioscler Thromb Vasc Biol (2015) 1.03
Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. J Control Release (2015) 0.87
Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models. J Transl Med (2015) 0.81
Monocytes and macrophages in abdominal aortic aneurysm. Nat Rev Cardiol (2017) 0.76
The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis. Sci Rep (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Inflammation in atherosclerosis. Nature (2002) 28.92
Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 19.60
Development of monocytes, macrophages, and dendritic cells. Science (2010) 12.86
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Hematopoiesis: an evolving paradigm for stem cell biology. Cell (2008) 11.95
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell (2008) 11.53
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity (2006) 11.28
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 9.54
Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest (2007) 9.09
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature (1998) 8.92
Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol (2009) 8.67
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
Macrophages in the pathogenesis of atherosclerosis. Cell (2011) 7.78
Stepwise reprogramming of B cells into macrophages. Cell (2004) 7.68
Monocyte recruitment during infection and inflammation. Nat Rev Immunol (2011) 7.55
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci (2007) 7.42
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity (2003) 7.33
IFNalpha activates dormant haematopoietic stem cells in vivo. Nature (2009) 7.17
Endothelial and perivascular cells maintain haematopoietic stem cells. Nature (2012) 6.60
Haematopoietic stem cell release is regulated by circadian oscillations. Nature (2008) 6.50
Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity (2012) 6.18
Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity (2006) 5.98
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76
The bone marrow niche for haematopoietic stem cells. Nature (2014) 5.06
Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol (2009) 5.03
Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature (2011) 4.71
Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science (2010) 4.67
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 4.56
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature (2013) 4.11
Tissue-resident macrophages. Nat Immunol (2013) 4.09
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature (2010) 3.93
The cellular and molecular origin of tumor-associated macrophages. Science (2014) 3.89
Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity (2011) 3.88
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med (2011) 3.88
Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol (2013) 3.85
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A (2004) 3.85
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation (2008) 3.69
Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity (2014) 3.54
Transcriptional control of granulocyte and monocyte development. Oncogene (2007) 3.49
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol (2002) 3.27
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood (2010) 3.26
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22
Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity (2012) 3.18
Comparison of gene expression profiles between human and mouse monocyte subsets. Blood (2009) 3.15
CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med (2009) 3.07
Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci U S A (2006) 3.00
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science (2013) 2.85
M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature (2013) 2.74
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol (2012) 2.73
The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol (2012) 2.69
Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity (2006) 2.58
The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell (1993) 2.55
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest (2011) 2.54
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature (2011) 2.44
Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell (2013) 2.42
Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol (2011) 2.38
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. J Clin Invest (2011) 2.37
ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity (2000) 2.34
The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J (2007) 2.34
Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes. Science (2013) 2.32
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab (2013) 2.20
Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med (2011) 2.18
Loss of gata1 but not gata2 converts erythropoiesis to myelopoiesis in zebrafish embryos. Dev Cell (2005) 2.12
MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell (1996) 2.08
Macrophages are required for adult salamander limb regeneration. Proc Natl Acad Sci U S A (2013) 2.07
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity (2012) 2.06
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab (2014) 1.96
Macrophages are required for neonatal heart regeneration. J Clin Invest (2014) 1.93
Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature (2014) 1.86
Origin of monocytes and macrophages in a committed progenitor. Nat Immunol (2013) 1.84
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res (2010) 1.82
Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J Am Coll Cardiol (2013) 1.82
Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res (2014) 1.78
An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS One (2012) 1.76
Chronic variable stress activates hematopoietic stem cells. Nat Med (2014) 1.70
LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest (2010) 1.67
Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity (2012) 1.63
Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell (2012) 1.62
Lymphoid tissue and plasmacytoid dendritic cells and macrophages do not share a common macrophage-dendritic cell-restricted progenitor. Immunity (2014) 1.56
Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell (2014) 1.55
Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res (2014) 1.52
Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circ Res (2013) 1.47
In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J Am Coll Cardiol (2013) 1.41
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45
Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A (2012) 2.42
PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol (2012) 2.39
Programming human pluripotent stem cells into white and brown adipocytes. Nat Cell Biol (2012) 2.26
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat Biotechnol (2013) 2.11
Innate response activator B cells protect against microbial sepsis. Science (2012) 2.07
Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med (2005) 2.03
Angiotensin II drives the production of tumor-promoting macrophages. Immunity (2013) 1.88
Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J (2013) 1.83
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res (2010) 1.82
Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res (2014) 1.78
18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjug Chem (2009) 1.78
Intraoperative near-infrared fluorescent cholangiography (NIRFC) in mouse models of bile duct injury. World J Surg (2010) 1.67
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res (2005) 1.66
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci U S A (2007) 1.65
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol (2008) 1.60
Real-time in vivo imaging of the beating mouse heart at microscopic resolution. Nat Commun (2012) 1.58
Molecular magnetic resonance imaging in cardiovascular medicine. Circulation (2007) 1.54
In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol (2006) 1.51
Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging (2006) 1.48
Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest (2010) 1.48
In vivo assessment of absolute perfusion in the murine skeletal muscle with spin labeling MRI. Magnetic resonance imaging. J Magn Reson Imaging (2003) 1.45
Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation. J Clin Invest (2008) 1.43
Tracheal tube obstruction in mechanically ventilated patients assessed by high-resolution computed tomography. Anesthesiology (2014) 1.41
Novel insights into LV remodeling after murine myocardial infarction by in vivo magnetic resonance tissue velocity mapping. Int J Cardiovasc Imaging (2004) 1.39
In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med (2011) 1.38
Molecular imaging of innate immune cell function in transplant rejection. Circulation (2009) 1.34
Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J (2012) 1.31
In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn Reson Med (2005) 1.31
Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circ Cardiovasc Imaging (2009) 1.30
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation (2013) 1.30
Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. Neoplasia (2009) 1.28
Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res (2011) 1.25
Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging (2008) 1.25
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells. Mol Ther Nucleic Acids (2012) 1.24
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation (2011) 1.23
Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21
Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors. PLoS One (2009) 1.20
Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep (2012) 1.19
Normalized Born ratio for fluorescence optical projection tomography. Opt Lett (2009) 1.17
Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circ Cardiovasc Imaging (2009) 1.16
89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjug Chem (2011) 1.14
Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res (2013) 1.11
Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models. PLoS One (2010) 1.10
Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. Circulation (2008) 1.10
Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc Natl Acad Sci U S A (2012) 1.09
Imaging of the unstable plaque: how far have we got? Eur Heart J (2009) 1.06
Monocyte heterogeneity in cardiovascular disease. Semin Immunopathol (2013) 1.05
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett (2012) 1.02
Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials (2010) 1.01
Nanoparticle-based monitoring of cell therapy. Nanotechnology (2011) 1.01
Volume catheter parallel conductance varies between end-systole and end-diastole. IEEE Trans Biomed Eng (2007) 1.00
In vivo time-resolved quantitative motion mapping of the murine myocardium with phase contrast MRI. Magn Reson Med (2003) 1.00
High throughput transmission optical projection tomography using low cost graphics processing unit. Opt Express (2009) 1.00
Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation (2014) 0.99
Molecular imaging of myocardial infarction. J Mol Cell Cardiol (2006) 0.99
Targeted imaging of myocardial damage. Nat Clin Pract Cardiovasc Med (2008) 0.97
Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation. J Am Chem Soc (2009) 0.95
Cardiac MRI in mice at 9.4 Tesla with a transmit-receive surface coil and a cardiac-tailored intensity-correction algorithm. J Magn Reson Imaging (2007) 0.94
Feasibility of real-time MRI with a novel carbon catheter for interventional electrophysiology. Circ Arrhythm Electrophysiol (2009) 0.93
Sequential average segmented microscopy for high signal-to-noise ratio motion-artifact-free in vivo heart imaging. Biomed Opt Express (2013) 0.93
Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries. Integr Biol (Camb) (2009) 0.91
Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol Imaging (2006) 0.90
Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell-selectin interaction kinetics. Biomaterials (2012) 0.89
Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. Expert Rev Mol Diagn (2013) 0.88
Cardiovascular molecular imaging: the road ahead. J Nucl Med (2012) 0.86
Healing and adverse remodelling after acute myocardial infarction: role of the cellular immune response. Heart (2012) 0.86
Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway. JACC Cardiovasc Imaging (2012) 0.84
Will molecular optical imaging have clinically important roles in stroke management, and how? J Clin Neurol (2010) 0.84
Born normalization for fluorescence optical projection tomography for whole heart imaging. J Vis Exp (2009) 0.84
Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts. Circ Cardiovasc Imaging (2013) 0.84
The ins and outs of inflammatory cells in atheromata. Cell Metab (2012) 0.84
Feasibility of contrast-enhanced and nonenhanced MRI for intraprocedural and postprocedural lesion visualization in interventional electrophysiology: animal studies and early delineation of isthmus ablation lesions in patients with typical atrial flutter. Circ Cardiovasc Imaging (2011) 0.83
Direct thrombus imaging as a means to control the variability of mouse embolic infarct models: the role of optical molecular imaging. Stroke (2011) 0.83
Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ Cardiovasc Imaging (2013) 0.83
Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarction. Circulation (2012) 0.83
Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque. Atherosclerosis (2011) 0.83
Molecular imaging of atherosclerosis: a progress report. Tex Heart Inst J (2010) 0.82
Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction. Circ Cardiovasc Imaging (2012) 0.82
Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase. Radiology (2011) 0.81
Intraoperative near-infrared fluorescent cholangiography (NIRFC) in mouse models of bile duct injury: reply. World J Surg (2011) 0.81
The journey from stem cell to macrophage. Ann N Y Acad Sci (2014) 0.81
MRI of a novel murine working heart transplant model. Circ Heart Fail (2009) 0.81
Imaging macrophage development and fate in atherosclerosis and myocardial infarction. Immunol Cell Biol (2012) 0.79
Endocarditis and molecular imaging. J Nucl Cardiol (2014) 0.79
Macrophage-stem cell crosstalk after myocardial infarction. J Am Coll Cardiol (2013) 0.78
Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed (2012) 0.78
Mapping molecular agents distributions in whole mice hearts using born-normalized optical projection tomography. PLoS One (2012) 0.77
Macrophages in the infarct: fiery friends or friendly fire? J Mol Cell Cardiol (2012) 0.77